Oxford Dementia Drug Discovery Institute (ODDI)
Oxford has one of three flagship Drug Discovry Institutes funded by Alzheimer’s Research UK. The team at Oxford is developing multiple projects to identify new therapeutic targets in Alzheimer's, Parkinson's and motor neuron disease. Professor Richard Wade-Martins is the Parkinson’s research lead on this £10M project.